1. Home
  2. Live Updates
  3. டிஜிட்டல் சர்வதேச கல்லீரல் காங்கிரஸ்

டிஜிட்டல் சர்வதேச கல்லீரல் காங்கிரஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from டிஜிட்டல் சர்வதேச கல்லீரல் காங்கிரஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In டிஜிட்டல் சர்வதேச கல்லீரல் காங்கிரஸ் Today - Breaking & Trending Today

4 Trending Health Care Stocks To Watch Right Now


Natera Inc (NASDAQ: NTRA)Cassava Sciences Inc
First, we have the clinical-stage biopharmaceutical company, Cassava. The company focuses on developing drugs for the treatment of nervous system disorders. Cassava is currently in focus due to the spotlight on the treatment of Alzheimer’s disease. This comes after Biogen Inc (NASDAQ: BIIB) received an accelerated FDA approval for its drug ADUHELM™. So, investors appear to be optimistic that Cassava’s simufilam and SavaDx may benefit from this development.  
Simufilam is Cassava’s lead drug candidate to treat Alzheimer’s disease while SavaDx is an investigational diagnostic candidate to detect Alzheimer’s. The company will be presenting its results of an interim analysis on safety and cognition for the first 50 subjects to complete 9 months of open-label drug treatment. These data will be presented at the 2021 Alzheimer’s Association International Conference (AAIC) in Denver scheduled fo ....

United States , Laboratory Test , Vir Biotechnology Inc , Cassava Sciences Inc , Top Health Care Stocks To Watch Right , Alzheimer Association International Conference , Biogen Inc , Digital International Liver Congress , Pfizer Inc , European Union , Moderna Inc , Research International , Committee For Medicinal Products Human Use , Centers For Medicare Medicaid Services , Drug Administration , Focusnatera Inc , European Medicines Agency , Emergency Use Authorization , Health Care Stocks To Watch Right , Association International Conference , Premier Research International , Premier Research , Medicinal Products , Human Use , Biotechnology Inc , Efficacy Trial ,

VBI Vaccines Inc. (via Public) / VBI Vaccines to Present at Upcoming Scientific Conferences (Form 8-K)

VBI Vaccines Inc. (via Public) / VBI Vaccines to Present at Upcoming Scientific Conferences (Form 8-K)
publicnow.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from publicnow.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Francisco Diaz Mitoma , Nicole Anderson , Vaccines Inc , Company Quarterly Reports On Form , Digital International Liver Congress , Corporate Communications , International Symposium On Viral Hepatitis , American Diabetes Association Virtual , Upcoming Scientific , Global Hepatitis Summit , American Diabetes Association , Hepatitis Summit , International Symposium , Viral Hepatitis , Liver Disease , Robust Immunogenicity , Rapid Onset , High Rates , Antigen Hepatitisb Vaccine , Medical Officer , Diabetes Association , Lower Nonresponse Rates , Obesity Compared , Annual Meeting ,

Vir Biotechnology Announces Multiple Abstracts Highlighting New Hepatitis B Data Accepted for Oral and Poster Presentations at EASL 2021

Vir Biotechnology Announces Multiple Abstracts Highlighting New Hepatitis B Data Accepted for Oral and Poster Presentations at EASL 2021
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New Zealand , United Kingdom , City Of , Kosh Agarwal , Edward Gane , Xencor Xtend , Heather Rowe Armstrong , Sneha Gupta , Fung Yuen , Vir Biotechnology Inc , Division Of Gastroenterology , Kings College Hospital , University Of Hong Kong , Institute Of Liver , Deputy Head Of Department Medicine , Alnylam Pharmaceuticals Inc , Digital International Liver Congress , Exchange Commission , Corporate Communications , Company Investors , University Of Auckland , European Association , Man Fung Yuen , Chair Professor , Deputy Head , Novel Therapeutic Approaches ,

Drug 'breakthrough' gives longest-ever survival in nonresectable liver cancer patients


Credit: EASL
6 February: The IMbrave150 trial found median overall survival was 19.2 months in patients treated with atezo+bev vs 13.4 months for those treated with sorafenib alone, the current standard treatment (HR, 0.66 [95% CI, 0.52-0.85]; P=0.0009). Survival at 18 months was 52% with atezo+bev and 40% in patients treated with sorafenib.
All patients in the trial had nonresectable HCC - the most common form of liver cancer - and had not previously been treated with systemic therapy. A total of 501 patients were treated in the multicentre, open label, randomised controlled trial and the new follow-up figures confirm the superiority of the atezo+bev combination over sorafenib in this group of patients with HCC. ....

Richard Finn , Digital International Liver Congress , International Liver Congress , European Association , Liver Cancer Summit , Digital Liver Cancer Summit , Medicine Health , Clinical Trials , Mortality Longevity , Public Health , ரிச்சர்ட் ஃபிந் , டிஜிட்டல் சர்வதேச கல்லீரல் காங்கிரஸ் , சர்வதேச கல்லீரல் காங்கிரஸ் , ஐரோப்பிய சங்கம் , கல்லீரல் புற்றுநோய் உச்சிமாநாடு , டிஜிட்டல் கல்லீரல் புற்றுநோய் உச்சிமாநாடு , மருந்து ஆரோக்கியம் , மருத்துவ சோதனைகள் , இறப்பு நீண்ட ஆயுள் , பொது ஆரோக்கியம் ,